uspto-grants-2010_06
uspto-grants-2010_06 · 10.6084/m9.figshare.5104873.v1 · US07737269B2
查看条件与参与物(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.2~3,6~.2~8,11~.2~13,16~.2~18,21~.2~23,26~]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol
IDENTITY
REACTIONS
uspto-grants-2010_06
uspto-grants-2010_06 · 10.6084/m9.figshare.5104873.v1 · US07737269B2
查看条件与参与物uspto-grants-2010_06
uspto-grants-2010_06 · 10.6084/m9.figshare.5104873.v1 · US07737269B2
查看条件与参与物uspto-grants-2010_06
uspto-grants-2010_06 · 10.6084/m9.figshare.5104873.v1 · US07737269B2
查看条件与参与物uspto-grants-2010_06
uspto-grants-2010_06 · 10.6084/m9.figshare.5104873.v1 · US07737269B2
查看条件与参与物uspto-grants-2013_07
uspto-grants-2013_07 · 10.6084/m9.figshare.5104873.v1 · US08481716B2
查看条件与参与物uspto-grants-2013_07
uspto-grants-2013_07 · 10.6084/m9.figshare.5104873.v1 · US08481716B2
查看条件与参与物uspto-grants-2013_07
uspto-grants-2013_07 · 10.6084/m9.figshare.5104873.v1 · US08481716B2
查看条件与参与物uspto-grants-2013_07
uspto-grants-2013_07 · 10.6084/m9.figshare.5104873.v1 · US08481716B2
查看条件与参与物